Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Automatic oxygen titration with O2matic® to patients admitted with COVID-19 and hypoxemic respiratory failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The Danish severe asthma register: an electronic platform for severe asthma management and research

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Inspiratory muscle strength and walking capacity in patients with COPD

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. NIV for acute respiratory failure in COPD: high in-hospital mortality is determined by patient selection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Introduction: Patients with coronavirus disease (COVID-19) and pneumonitis often have hypoxemic respiratory failure and a need of supplementary oxygen. Guidelines recommend controlled oxygen, for most patients with a recommended interval of SpO2 between 92 and 96%. We aimed to determine if closed-loop control of oxygen was feasible in patients with COVID-19 and could maintain SpO2 in the specified interval.

Methods: Patients were prospectively enrolled in an observational study on a medical ward dedicated to patients with COVID-19. Closed-loop controlled oxygen was delivered by O2matic® which can deliver 0-15 liters/min and adjusts flow every second based on 15 seconds averaging of SpO2 measured by pulse oximetry. Lung function parameters were measured at admission.

Results: Fifteen patients (six women, nine men) participated in the study. Average age was 72 years. Lung function was severely impaired with FEV1, FVC and PEF reduced to approximately 50%. The average stay on the ward was 3.2 days and O2matic was used on average for 66 hours, providing 987 hours of observation. O2matic maintained SpO2 in the desired interval for 82.9% of the time. Time with SpO2 > 2% below interval was 5.1% and time with SpO2 > 2% above interval was 0.6%.

Conclusion: Closed-loop control of oxygen to patients with COVID-19 is feasible and can maintain SpO2 in the specified interval in the majority of time. Closed-loop automated control could be of particular benefit for patients in isolation with decreased visibility, surveillance and monitoring. Further studies must examine the clinical benefits.

OriginalsprogEngelsk
TidsskriftEuropean Clinical Respiratory Journal
Vol/bind7
Udgave nummer1
Sider (fra-til)1833695
ISSN2001-8525
DOI
StatusUdgivet - 14 okt. 2020

Bibliografisk note

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

ID: 61235043